Verastem Statistics
NASDAQ: VSTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.04-0.23 (-2.78%)
Market open · Delayed 15 min · as of Oct 8, 1:39 PM ET
Verastem by the numbers
Verastem has a market capitalization of $727.7 million based on 90.56M shares outstanding. With trailing EPS of $-2.45, Verastem is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.3% above its 50-day average and 33.1% above its 200-day average.
Average daily trading volume is 2.29M shares, or about $18.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VSTM valuation vs. peer median
| Metric | VSTM | Peer median | Difference |
|---|---|---|---|
| Market cap | $727.68M | $764.95M | -5% |
| Avg. volume | 2.29M | 1.71M | +33% |
Peer median across 8 companies: ANNX, LXRX, HELP, APMD, GYRE, IMMX, OBX, GERN.
Valuation
- Market cap
- $727.68M
- EPS (TTM)
- $-2.45
- Shares outstanding
- 90.56M
Price and trading
- Previous close
- 8.27
- Open
- 8.20
- Day range
- 7.72 – 8.28
- 52-week range
- 3.43 – 10.82
- 52-week change
- -8.17%
- Beta
- —
- Volume
- 1.40M
- Average volume
- 2.29M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 727.68M
- Forward Pe
- -10.71
- Eps
- -2.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.82
- Week52 Low
- 3.43
- Avg Volume
- 2.29M
- Shares Outstanding
- 90.56M
- Ma50
- 7.28
- Ma200
- 6.04
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -25.74%
- Pct From52w Low
- 134.26%